Clinical Trial Update: DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating DHA (docosahexaenoic acid) supplementation to improve insulin sensitivity in overweight pregnant women; the study status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus
• Hypertension in Pregnancy
• Insulin Resistance
• Obesity
• Preeclampsia

Drugs mentioned

• Docosahexaenoic acid (DHA) supplementation (docosahexaenoic acid)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Overweight and Obesity, Insulin Resistance | Phase 1 | Status: UNKNOWN